Uploaded June 2020 | Updated September 2026, 2 hours ago
The Rockefeller University
Virtual Discussions with Genuine Experts Webinar Series
May 14, 2020
Speakers:
Richard P. Lifton, M.D., Ph.D., President and Carson Family Professor
Laboratory of Human Genetics and Genomics, The Rockefeller University
Marina Caskey, M.D., Associate Professor of Clinical Investigation
Laboratory of Molecular Immunology, The Rockefeller University
Rockefeller University experts in infectious disease, immunology, biochemistry, structural biology, and genetics have projects underway that are aimed at understanding, preventing, and treating the SARS-CoV-2 virus, which is responsible for the current global COVID-19 pandemic. Dr. Marina Caskey is among the many Rockefeller experts pursuing the development of much-needed therapies for COVID-19. In collaboration with Michel Nussenzweig, M.D., Ph.D., she is currently leading clinical efforts to identify and evaluate exceptionally potent antibodies against the novel coronavirus—antibodies that are derived from patients who have recovered from the viral disease. Hosted by President Rick Lifton. For more information, visit: https://covid-19-research.rockefeller.edu.
The Rockefeller University
Virtual Discussions with Genuine Experts Webinar Series
May 14, 2020
Speakers:
Richard P. Lifton, M.D., Ph.D., President and Carson Family Professor
Laboratory of Human Genetics and Genomics, The Rockefeller University
Marina Caskey, M.D., Associate Professor of Clinical Investigation
Laboratory of Molecular Immunology, The Rockefeller University
Rockefeller University experts in infectious disease, immunology, biochemistry, structural biology, and genetics have projects underway that are aimed at understanding, preventing, and treating the SARS-CoV-2 virus, which is responsible for the current global COVID-19 pandemic. Dr. Marina Caskey is among the many Rockefeller experts pursuing the development of much-needed therapies for COVID-19. In collaboration with Michel Nussenzweig, M.D., Ph.D., she is currently leading clinical efforts to identify and evaluate exceptionally potent antibodies against the novel coronavirus—antibodies that are derived from patients who have recovered from the viral disease. Hosted by President Rick Lifton. For more information, visit: https://covid-19-research.rockefeller.edu.
